PADI4 and breast carcinoma: In summary, this study confirmed that PADI4 is expressed on cell membranes, and membrane-expressed PADI4 stimulates the growth, metastasis and glycolysis of tumor cells, and anti-PADI4 monoclonal antibody can inhibit the biological activity of breast cancer cells by inhibiting the expression of membrane PADI4.